Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1019

1.

How Safe Are Safety-Net Hospitals? Opportunities to Improve Outcomes for Vulnerable Patients Undergoing Hepatopancreaticobiliary Surgery.

Farooq A, Paredes AZ, Merath K, Hyer JM, Mehta R, Sahara K, Tsilimigras DI, Moro A, Wu L, Cloyd J, Ejaz A, Pawlik TM.

J Gastrointest Surg. 2019 Dec 2. doi: 10.1007/s11605-019-04428-1. [Epub ahead of print]

PMID:
31792898
2.

CMS Hospital Compare System of Star Ratings and Surgical Outcomes Among Patients Undergoing Surgery for Cancer: Do the Ratings Matter?

Mehta R, Paredes AZ, Tsilimigras DI, Farooq A, Sahara K, Merath K, Hyer JM, White S, Ejaz A, Tsung A, Dillhoff M, Cloyd JM, Pawlik TM.

Ann Surg Oncol. 2019 Dec 2. doi: 10.1245/s10434-019-08088-y. [Epub ahead of print]

PMID:
31792714
3.

Redefining the "Honor Roll:" do hospital rankings predict surgical outcomes or receipt of quality surgical care?

Mehta R, Paredes AZ, Pawlik TM.

Am J Surg. 2019 Nov 26. pii: S0002-9610(19)31543-0. doi: 10.1016/j.amjsurg.2019.11.029. [Epub ahead of print]

PMID:
31791549
4.
5.

Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.

Xia Y, Li J, Liu G, Wang K, Qian G, Lu Z, Yang T, Yan Z, Lei Z, Si A, Wan X, Zhang H, Gao C, Cheng Z, Pawlik TM, Wang H, Lau WY, Wu M, Shen F.

JAMA Oncol. 2019 Nov 27. doi: 10.1001/jamaoncol.2019.4477. [Epub ahead of print]

PMID:
31774468
6.

New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors.

Scoville SD, Cloyd JM, Pawlik TM.

Expert Opin Pharmacother. 2019 Nov 24:1-9. doi: 10.1080/14656566.2019.1694003. [Epub ahead of print]

PMID:
31760823
7.

Precision Medicine in Surgical Oncology.

Pawlik TM.

Surg Oncol Clin N Am. 2020 Jan;29(1):xiii-xiv. doi: 10.1016/j.soc.2019.09.002. No abstract available.

PMID:
31757317
8.

Impact of Preoperative Cholangitis on Short-term Outcomes Among Patients Undergoing Liver Resection.

Sahara K, Merath K, Hyer JM, Paredes AZ, Tsilimigras DI, Mehta R, Farooq SA, Moro A, Wu L, White S, Endo I, Pawlik TM.

J Gastrointest Surg. 2019 Nov 19. doi: 10.1007/s11605-019-04430-7. [Epub ahead of print]

PMID:
31745898
9.

Interaction of Surgeon Volume and Nurse-to-Patient Ratio on Post-operative Outcomes of Medicare Beneficiaries Following Pancreaticoduodenectomy.

Paredes AZ, Hyer JM, Tsilimigras DI, Sahara K, White S, Pawlik TM.

J Gastrointest Surg. 2019 Nov 19. doi: 10.1007/s11605-019-04449-w. [Epub ahead of print]

PMID:
31745895
10.

Photodynamic therapy may provide a benefit over systemic chemotherapy among non-surgically managed patients with extrahepatic cholangiocarcinoma.

Wu L, Merath K, Farooq A, Hyer JM, Tsilimigras DI, Paredes AZ, Mehta R, Sahara K, Shen F, Pawlik TM.

J Surg Oncol. 2019 Nov 19. doi: 10.1002/jso.25773. [Epub ahead of print]

PMID:
31742706
11.

A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients.

Tsilimigras DI, Mehta R, Moris D, Sahara K, Bagante F, Paredes AZ, Moro A, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Nov 14. doi: 10.1245/s10434-019-08067-3. [Epub ahead of print]

PMID:
31728792
12.

ASO Author Reflections: Use of Machine Learning to Identify Patients with Intrahepatic Cholangiocarcinoma Who Could Benefit More from Neoadjuvant Therapies.

Tsilimigras DI, Mehta R, Pawlik TM.

Ann Surg Oncol. 2019 Nov 11. doi: 10.1245/s10434-019-08068-2. [Epub ahead of print] No abstract available.

PMID:
31712926
13.

Accessing surgical care for pancreaticoduodenectomy: Patient variation in travel distance and choice to bypass hospitals to reach higher volume centers.

Diaz A, Burns S, Paredes AZ, Pawlik TM.

J Surg Oncol. 2019 Dec;120(8):1318-1326. doi: 10.1002/jso.25750. Epub 2019 Nov 7.

PMID:
31701535
14.

Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.

Tsilimigras DI, Mehta R, Moris D, Sahara K, Bagante F, Paredes AZ, Farooq A, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Nov 6. doi: 10.1245/s10434-019-08025-z. [Epub ahead of print]

PMID:
31696396
15.

ASO Author Reflections: Resection for Hepatocellular Carcinoma Beyond the BCLC Guidelines-How Can Machine Learning Techniques Help?

Tsilimigras DI, Pawlik TM.

Ann Surg Oncol. 2019 Nov 4. doi: 10.1245/s10434-019-08036-w. [Epub ahead of print] No abstract available.

PMID:
31686343
16.

U.S. News and World Report hospital ranking and surgical outcomes among patients undergoing surgery for cancer.

Mehta R, Merath K, Farooq A, Sahara K, Tsilimigras DI, Ejaz A, Hyer JM, Paredes AZ, Dillhoff M, Cloyd JM, Pawlik TM.

J Surg Oncol. 2019 Dec;120(8):1327-1334. doi: 10.1002/jso.25751. Epub 2019 Nov 3.

PMID:
31680251
17.

Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.

Zhang XF, Wu XN, Tsilimigras DI, Poultsides G, Rocha F, Abbott DE, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(8):1302-1310. doi: 10.1002/jso.25753. Epub 2019 Nov 3.

PMID:
31680243
18.

A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.

Yang T, Xing H, Wang G, Wang N, Liu M, Yan C, Li H, Wei L, Li S, Fan Z, Shi M, Chen W, Cai S, Pawlik TM, Soh A, Beshiri A, Lau WY, Wu M, Zheng Y, Shen F.

Clin Chem. 2019 Dec;65(12):1543-1553. doi: 10.1373/clinchem.2019.308965. Epub 2019 Oct 31.

PMID:
31672853
19.

Can We Improve Prediction of Adverse Surgical Outcomes? Development of a Surgical Complexity Score Using a Novel Machine Learning Technique.

Hyer JM, White S, Cloyd J, Dillhoff M, Tsung A, Pawlik TM, Ejaz A.

J Am Coll Surg. 2019 Oct 28. pii: S1072-7515(19)32118-0. doi: 10.1016/j.jamcollsurg.2019.09.015. [Epub ahead of print]

PMID:
31672674
20.

Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?

Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM.

Ann Surg Oncol. 2019 Oct 28. doi: 10.1245/s10434-019-07964-x. [Epub ahead of print]

PMID:
31659645
21.

Coaxial projective imaging system for surgical navigation and telementoring.

Zhang F, Zhu X, Gao J, Wu B, Liu P, Shao P, Xu M, Pawlik TM, Martin EW, Xu RX.

J Biomed Opt. 2019 Oct;24(10):1-9. doi: 10.1117/1.JBO.24.10.105002.

22.

Routine Intensive Care Unit Admission Following Liver Resection: What Is the Value Proposition?

Merath K, Cerullo M, Farooq A, Canner JK, He J, Tsilimigras DI, Mehta R, Paredes AZ, Sahara K, Dillhoff M, Tsung A, Cloyd J, Ejaz A, Pawlik TM.

J Gastrointest Surg. 2019 Oct 19. doi: 10.1007/s11605-019-04408-5. [Epub ahead of print]

PMID:
31630368
23.

Understanding the use of attachment theory applied to the patient-provider relationship in cancer care: Recommendations for future research and clinical practice.

Palmer Kelly E, Tsilimigras DI, Hyer JM, Pawlik TM.

Surg Oncol. 2019 Dec;31:101-110. doi: 10.1016/j.suronc.2019.10.007. Epub 2019 Oct 5. Review.

PMID:
31622916
24.

Hepatopancreatobiliary Surgery: the Role of Clinical Resources and Variation in Performance of Hospitals Located in "Distressed" Communities.

Farooq A, Paredes AZ, Merath K, Mehta R, Moro A, Wu L, Sahara K, Hyer JM, Tsilimigras DI, Diaz A, Pawlik TM.

J Gastrointest Surg. 2019 Oct 16. doi: 10.1007/s11605-019-04401-y. [Epub ahead of print]

PMID:
31621025
25.

Evaluation of costs and outcomes of physician-owned hospitals across common surgical procedures.

Bae J, Hyer JM, Paredes AZ, Farooq A, Rice DR, White S, Tsilimigras DI, Ejaz A, Pawlik TM.

Am J Surg. 2019 Oct 8. pii: S0002-9610(19)31187-0. doi: 10.1016/j.amjsurg.2019.10.008. [Epub ahead of print]

PMID:
31619377
26.

Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.

Klompenhouwer AJ, Dwarkasing RS, Doukas M, Pellegrino S, Vilgrain V, Paradis V, Soubrane O, Beane JD, Geller DA, Nalesnik MA, Tripke V, Lang H, Schmelzle M, Pratschke J, Schöning W, Beal E, Sun S, Pawlik TM, de Man RA, Ijzermans JNM.

HPB (Oxford). 2019 Oct 13. pii: S1365-182X(19)30716-6. doi: 10.1016/j.hpb.2019.09.004. [Epub ahead of print]

PMID:
31619346
27.

Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population-based analysis.

Wu L, Tsilimigras DI, Farooq A, Hyer JM, Merath K, Paredes AZ, Mehta R, Sahara K, Shen F, Pawlik TM.

J Surg Oncol. 2019 Dec;120(8):1358-1364. doi: 10.1002/jso.25736. Epub 2019 Oct 15.

PMID:
31614000
28.

Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study.

Xing H, Zhang WG, Cescon M, Liang L, Li C, Wang MD, Wu H, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Schwartz M, Pawlik TM, Serenari M, Shen F, Wu MC, Yang T.

HPB (Oxford). 2019 Oct 10. pii: S1365-182X(19)30718-X. doi: 10.1016/j.hpb.2019.09.006. [Epub ahead of print]

PMID:
31607637
29.

Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.

Tsilimigras DI, Bagante F, Moris D, Merath K, Paredes AZ, Sahara K, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Surgery. 2019 Dec;166(6):967-974. doi: 10.1016/j.surg.2019.08.010. Epub 2019 Oct 9.

PMID:
31606196
30.

Correction to: Current Approaches in the Management of Hepatic Adenomas.

Tsilimigras DI, Rahnemai-Azar AA, Ntanasis-Stathopoulos I, Gavriatopoulou M, Moris D, Spartalis E, Cloyd JM, Weber SM, Pawlik TM.

J Gastrointest Surg. 2019 Oct 10. doi: 10.1007/s11605-019-04372-0. [Epub ahead of print]

PMID:
31602557
31.

Hepatocellular carcinoma: an update on investigational drugs in phase I and II clinical trials.

Noonan A, Pawlik TM.

Expert Opin Investig Drugs. 2019 Nov;28(11):941-949. doi: 10.1080/13543784.2019.1677606. Epub 2019 Oct 12. Review.

PMID:
31590579
32.

Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases.

Dong DH, Zhang XF, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1071-1079. doi: 10.1002/jso.25716. Epub 2019 Sep 30.

PMID:
31571225
33.

Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM.

Am J Surg. 2019 Sep 19. pii: S0002-9610(19)30848-7. doi: 10.1016/j.amjsurg.2019.09.017. [Epub ahead of print]

PMID:
31558307
34.

Advances in the Diagnosis and Treatment of Patients with Intrahepatic Cholangiocarcinoma.

Ejaz A, Cloyd JM, Pawlik TM.

Ann Surg Oncol. 2019 Sep 25. doi: 10.1245/s10434-019-07873-z. [Epub ahead of print]

PMID:
31555936
35.

Complex hepato-pancreato-biliary caseload during general surgery residency training: are we adequately training the next generation?

Diaz A, Schoenbrunner A, Dillhoff M, Cloyd JM, Ejaz A, Tsung A, Shirley LA, Harzman AE, Cochran A, Pawlik TM.

HPB (Oxford). 2019 Sep 21. pii: S1365-182X(19)30709-9. doi: 10.1016/j.hpb.2019.08.017. [Epub ahead of print]

PMID:
31551139
36.

Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis.

Sahara K, Merath K, Tsilimigras DI, Hyer JM, Guglielmi A, Aldrighetti L, Weiss M, Fields RC, Poultsides GA, Maithel SK, Endo I, Pawlik TM, Other Members Of The U S Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1087-1095. doi: 10.1002/jso.25713. Epub 2019 Sep 24.

PMID:
31550406
37.

Real-world role of performance status in surgical resection for hepatocellular carcinoma: A multicenter study.

Wu H, Xing H, Liang L, Huang B, Li C, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zhang YM, Zeng YY, Pawlik TM, Wang MD, Wu MC, Shen F, Yang T.

Eur J Surg Oncol. 2019 Dec;45(12):2360-2368. doi: 10.1016/j.ejso.2019.09.009. Epub 2019 Sep 12.

PMID:
31543386
38.

Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review.

Montalvo-Jave EE, Rahnemai-Azar AA, Papaconstantinou D, Deloiza ME, Tsilimigras DI, Moris D, Mendoza-Barrera GE, Weber SM, Pawlik TM.

Surg Oncol. 2019 Dec;31:83-89. doi: 10.1016/j.suronc.2019.09.006. Epub 2019 Sep 13. Review.

PMID:
31541911
39.

The Association Between Patient Satisfaction and Patient-Reported Health Outcomes.

Chen Q, Beal EW, Okunrintemi V, Cerier E, Paredes A, Sun S, Olsen G, Pawlik TM.

J Patient Exp. 2019 Sep;6(3):201-209. doi: 10.1177/2374373518795414. Epub 2018 Aug 27.

40.

Is Annual Preoperative Utilization an Indicator of Postoperative Surgical Outcomes? A Study in Medicare Expenditure.

Hyer JM, Tsilimigras DI, Paredes AZ, Sahara K, White S, Pawlik TM.

World J Surg. 2019 Sep 17. doi: 10.1007/s00268-019-05184-8. [Epub ahead of print]

PMID:
31531723
41.

Correction to: Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.

Spolverato G, Bagante F, Aldrighetti L, Poultsides G, Bauer TW, Fields RC, Marques HP, Weiss M, Maithel SK, Pawlik TM.

J Gastrointest Surg. 2019 Sep 16. doi: 10.1007/s11605-019-04371-1. [Epub ahead of print]

PMID:
31529199
42.

Association of Depression Risk with Patient Experience, Healthcare Expenditure, and Health Resource Utilization Among Adults with Atherosclerotic Cardiovascular Disease.

Okunrintemi V, Valero-Elizondo J, Michos ED, Salami JA, Ogunmoroti O, Osondu C, Tibuakuu M, Benson EM, Pawlik TM, Blaha MJ, Nasir K.

J Gen Intern Med. 2019 Nov;34(11):2427-2434. doi: 10.1007/s11606-019-05325-8. Epub 2019 Sep 5.

PMID:
31489560
43.

Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.

Li C, Wang MD, Lu L, Wu H, Yu JJ, Zhang WG, Pawlik TM, Zhang YM, Zhou YH, Gu WM, Wang H, Chen TH, Han J, Xing H, Li ZL, Lau WY, Wu MC, Shen F, Yang T.

Hepatol Int. 2019 Nov;13(6):736-747. doi: 10.1007/s12072-019-09981-0. Epub 2019 Sep 5.

PMID:
31486964
44.

Patient Perceptions About the Role of Religion and Spirituality During Cancer Care.

Merath K, Palmer Kelly E, Hyer JM, Mehta R, Agne JL, Deans K, Fischer BA, Pawlik TM.

J Relig Health. 2019 Sep 3. doi: 10.1007/s10943-019-00907-6. [Epub ahead of print]

PMID:
31482443
45.

Response: Oncologic outcomes of minimally invasive vs open distal pancreatectomy for pancreatic neuroendocrine tumors: Randomized controlled trials are needed.

Zhang XF, Pawlik TM.

J Surg Oncol. 2019 Dec;120(7):1286. doi: 10.1002/jso.25693. Epub 2019 Sep 2. No abstract available.

PMID:
31476082
46.

Biliary Tract and Primary Liver Tumors.

Pawlik TM.

Surg Oncol Clin N Am. 2019 Oct;28(4):xiii-xiv. doi: 10.1016/j.soc.2019.07.002. Epub 2019 Jul 26. No abstract available.

PMID:
31472919
47.

Intrahepatic Cholangiocarcinoma.

El-Diwany R, Pawlik TM, Ejaz A.

Surg Oncol Clin N Am. 2019 Oct;28(4):587-599. doi: 10.1016/j.soc.2019.06.002. Review.

PMID:
31472907
48.

Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.

Wu L, Sahara K, Tsilimigras DI, Maithel SK, Poultsides GA, Rocha FG, Weber SM, Fields RC, Idrees K, Cho CS, Shen F, Pawlik TM; and other members of the U.S. Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1080-1086. doi: 10.1002/jso.25689. Epub 2019 Aug 29.

PMID:
31468550
49.

Clinical Utility of Autologous Salvaged Blood: a Review.

Frank SM, Sikorski RA, Konig G, Tsilimigras DI, Hartmann J, Popovsky MA, Pawlik TM, Waters JH.

J Gastrointest Surg. 2019 Aug 29. doi: 10.1007/s11605-019-04374-y. [Epub ahead of print]

PMID:
31468332
50.

Handheld projective imaging device for near-infrared fluorescence imaging and intraoperative guidance of sentinel lymph node resection.

Li C, Liu P, Shao P, Pei J, Li Y, Pawlik TM, Martin EW, Xu RX.

J Biomed Opt. 2019 Aug;24(8):1-4. doi: 10.1117/1.JBO.24.8.080503.

Supplemental Content

Loading ...
Support Center